T. Shibue
Oncology · 2000–2017
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 117 citations into it; #1,605 of 1,698 by trust here, #376 by citations
- Molecular Biology — 106 citations into it; #17,059 of 17,773 by trust here, #4,299 by citations
- Cancer Research — 42 citations into it
Whom T. Shibue trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Shibue overall
Papers from T. Shibue's perspective
Ordered by how strongly the researchers T. Shibue trusts endorse each paper. Same corpus, a different order for every researcher.
- The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (Nature Medicine)
- Stem cells, cancer, and cancer stem cells (Nature)
- Molecular requirements for epithelial-mesenchymal transition during tumor progression. (Current Opinion in Cell Biology)
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition (PLoS ONE)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- Generation of a functional mammary gland from a single stem cell (Nature)
- Stem cell concepts renew cancer research. (Blood)
- Purification and unique properties of mammary epithelial stem cells (Nature)
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells (Nature)
Their papers
- Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. (2000) — 2,214 citations
- Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State (2012) — 991 citations
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells (2015) — 662 citations
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications (2017) — 2,297 citations
- Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence (2003) — 629 citations